Lymphatic filariasis in India: Epidemiology and control measures

Journal of Postgraduate Medicine

Volumn 56, Issue 3, 2010, Pages 232-238

  Sabesan, S ^a   Vanamail, P ^a   Raju, K H K ^a   Jambulingam, P ^a  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

Author keywords

control strategy; elimination; epidemiology; India; Lymphatic filariasis

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; DNA; ANTIFILARIAL AGENT;

BRUGIA MALAYI; CHRONIC DISEASE; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FILARIASIS; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INDIA; INFECTION CONTROL; INFECTION RISK; LYMPHATIC FILARIASIS; NONHUMAN; PARASITE PREVALENCE; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PUBLIC HEALTH PROBLEM; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; WORLD HEALTH ORGANIZATION; WUCHERERIA BANCROFTI; ANIMAL; DISEASE CARRIER; DRUG EFFECTS; ELEPHANTIASIS, FILARIAL; ENDEMIC DISEASES; ISOLATION AND PURIFICATION; MOSQUITO; PARASITOLOGY; PREVALENCE; PROCEDURES; TRANSMISSION; TREATMENT OUTCOME;

ANIMALS; BRUGIA MALAYI; DIETHYLCARBAMAZINE; DISEASE VECTORS; ELEPHANTIASIS, FILARIAL; ENDEMIC DISEASES; FILARICIDES; HEALTH POLICY; HUMANS; INDIA; MOSQUITO CONTROL; PREVALENCE; TREATMENT OUTCOME; WUCHERERIA BANCROFTI;

EID: 77956364029     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.68650     Document Type: Review

References (64)

1. Sabesan S, Palaniyandi M, Das PK, Michael E. Mapping of lymphatic filariasis in India. Ann Trop Med Parasitol 2000;94:591-606.
2. Raghavan NG. National filaria control programme: A review. Bull Nat Soc Ind Mal Mosq Dis 1955;3:175-184
3. Rajagopalan PK, Das PK, Subramanian S, Vanamail P, Ramaiah KD. Bancroftian filariasis in Pondicherry, South India: 1, Pre-control epidemiological observations. Epidemiol Infect 1989;103:685-692
4. Subramanian S, Pani S P, Das PK, Rajagopalan PK. Bancroftian filariasis in Pondicherry, South India: 2, Epidemiological evaluation of the effect of vector control. Epidemiol Infect 1989;103:693-702.
5. Pani S P, Balakrishnan N, Srividya A, Bundy DAP, Grenfell BT. Clinical epidemiology of bancroftian filariasis: Effect of age and gender. Trans R Soc Trop Med Hyg 1991;85:260-264
6. Sabesan S, Krishnamoorthy K, Pani S P, Panicker KN. Mandays lost due to repeated acute attacks of lymphatic filariasis. Trends Life Sci 1992;7:5-7.
7. Tewari SC, Hiriyan JH, Reuben R. Epidemiology of subperiodic W. bancrofti infection in the Nicobar Islands, India. Trans R Soc Trop Med Hyg 1995;89:163-166
8. Ramaiah KD, Ramu K, Vijaya Kumar KN, Guyatt H. Epidemiology of acute filarial episodes caused by Wuchereria bancrofti infection in two rural villages in Tamil Nadu, south India. Trans R Soc Trop Med Hyg 1996;90:639-643
9. Ramaiah KD, Vijaya Kumar KN. Effect of lymphatic filariasis on school children. Acta Trop 2000;76:197-199
10. Pani S P, Balakrishnan N, Srividya A, Bundy DA, Grenfell BT. Clinical epidemiology of bancroftian filariasis: Effect of age and gender. Trans R Soc Trop Med Hyg 1991;85:260-264
11. Pani S P, Yuvaraj J, Vanamail P, Dhanda V, Michael E, Grenfell BT, et al. Episodic adenolymphangitis and lymphoedema in patients with bancroftian filariasis. Trans R Soc Trop Med Hyg 1995;89:72-74
12. Das PK, Manoharan A, Subramanian S, Ramaiah KD, Pani S P, Rajavel AR, et al. Bancroftian filariasis in Pondicherry, South India: Epidemiological impact of recovery of the vector population. Epidemiol Infect 1992;108:483-493
13. Nair C P. Filariasis in centrally administered areas: Part I: Filaria surveys of Pondicherry settlement. India J Malariol 1960;13:233-252
14. Das PK, Manoharan A, Srividya A, Grenfell B T, Bundy DA, Vanamail P, et al. Frequency distribution of Wuchereria bancrofti microfilariae in human populations and its relationships with age and sex. Parasitology 1990;101:429-434
15. Rajagopalan PK, Menon PK, Brooks GD. A study on some aspects of Culex pipiens fatigans population in an urban area, Faridabad, northern India. Indian J Med Res 1977;65:65-76.
16. Vanamail P, Subramanian S, Das PK, Pani S P, Rajagopalan PK, Bundy DA, et al. Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofti infection. Trans R Soc Trop Med Hyg 1989;83:689-693
17. Vanamail P, Ramaiah KD, Pani S P, Das PK, Grenfell BT, Bundy DA. Estimation of the fecund life span of Wuchereria bancrofti in an endemic area. Trans R Soc Trop Med Hyg 1996;90:119-121
18. Sabesan S, Pradeep Kumar N, Rajendran G, Krishnamoorthy K. The Cherthala Project: Control of brugian filariasis through integrated methods. Misc Pub VCRC 2000;2:1-23.
19. Panicker KN, Krishnamoorthy K, Sabesan S, Prathiba J, Abidha. Comparison of effects of mass annual and biannual single dose therapy with diethylcarbamazine for the control of Malayan filariasis. Southeast Asian J Trop Med Public Health 1991;22:402-411
20. Balakrishnan N, Ramaiah KD, Pani S P. Efficacy of Bi-annual administration of DEC in the control of bancroftian filariasis. J Commun Dis 1992;24:87-91.
21. Ottesen EA, Duke BO, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997;1:153-194
22. World Health Assembly. Elimination of lymphatic filariasis as a public health problem. Geneva: WHO; 1997. p. 50.
23. Molyneux DH, Zagaria N. Lymphatic filariasis elimination: Progress in global programme development. Ann Trop Med Parasitol 2002;96:S15-40.
24. Carme B, Laigret J. Longevity of Wuchereria bancrofti var. pacifica and mosquito infection acquired from a patient with low level parasitemia. Am J Trop Med Hyg 1979;28:53-55
25. Mak JW. Epidemiology of lymphatic filariasis. Ciba Found Symp 1987;127:5-14.
26. WHO. Sixth meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, Geneva, Switzerland. Wkly Epidemiol Rec 2005;80:401-408
27. Regu K, Rajendran R, Ali MK, Koya SM, Dhariwal AC, Lal S. Decline of brugian filariasis in Cherthala taluk, Alappuzha district, Kerala. J Commun Dis 2005;37:209-218
28. National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. Website: Available from http://nvbdcp.gov.in/filariasis-new.html. [cited on 2010 Jan 13].
29. Sabesan S, Ravi R, Das PK. Elimination of lymphatic filariasis in India. Lancet Infect Dis 2005;5:4-5.
30. WHO: Lymphatic filariasis infection and disease: Control strategies. Report of a consultative meeting held at the Universiti Sains Malaysia, Penang, Malaysia. Geneva: World Health Organization, mimeographed document WHO/TDR/CTD/FIL/PENANG 1994; 94:1-30.
31. Ramaiah KD, Pani S P, Balakrishnan N, Sadanandane C, Das LK, Mariappan T, et al. Prevalence of bancroftian filariasis and its control by single course of diethylcarbamazine in a rural area in Tamil Nadu. Indian J Med Res 1989;89:184-191
32. Pani S P, Das LK, Balakrishnan N, Sadanandane C, Rajavel AR, Subramanian S, et al. A study on the clinical manifestations of Bancroftian filariasis in Pondicherry. Indian Med Gazette 1989;CXXII:111-115
33. Rao CK, Rao PK, Prasad KR. Epidemiological studies on bancroftian filariasis in East Godavari district (Andhra Pradesh): II, Periodicity of microfilaria. J Commun Dis 1980;12:164-166
34. Rath RN, Das RK, Mishra G, Mohapatra BN, Ramakrishna C. Bancroftian filariasis in two selected rural communities in Puri district: Orissa: A comparative study of filariometric data. J Commun Dis 1984;16:104-112
35. Sarma RV, Vallishayee RS, Mayurnath S, Narayanan PR, Radhamani M, Tripathy S P. Prevalence survey of filariasis in two villages in Chingleput district of Tamil Nadu. Indian J Med Res 1987;85:522-530
36. Surendran K, Pani S P, Soudarssanane MB, Srinivasa DK, Bordolai PC, Subramanian S. Natural history, trend of prevalence and spectrum of manifestations of bancroftian filarial disease in Pondicherry (South India). Acta Trop 1996;61:9-18.
37. Sabesan S. Lymphatic filariasis: Early diagnosis and treatment. Physician's Digest 2005;14:28-36.
38. Chan MS, Srividya A, Norman RA, Pani S P, Ramaiah KD, Vanamail P, et al. EPIFIL: A dynamic model of infection and disease in lymphatic filariasis. Am J Trop Med Hyg 1998;59:606-614
39. Norman RA, Chan MS, Srividya A, Pani S P, Ramaiah KD, Vanamail P, et al. EPIFIL: The development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect 2000;124:529-541
40. Plaisier A P, Subramanian S, Das PK, Souza W, Lapa T, Furtado A F, et al. The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Met Inf Med 1998;37:97-108.
41. Stolk WA, Subramanian S, van Oortmarssen GJ, Das PK, Habbema JD. Prospects of elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: A simulation study. J Infect Dis 2003;188:1371-1381
42. Subramanian S, Stolk WA, Ramaiah KD, Plaisier A P, Krishnamoorthy K, Van Oortmarssen GJ, et al. The dynamics of Wuchereria bancrofti infection: A model-based analysis of longitudinal data from Pondicherry, India. Parasitology 2004;128:467-482
43. Govt. of India, Ministry of Health and Family Welfare: National vector borne diseases control programme; Problems and elimination of lymphatic filariasis in India. 2005. Available from http://www.namp. gov.in/filariasis. html. [cited on 2010 Jan 12].
44. Pani S P, Subramanyam Reddy G, Das LK, Vanamail P, Hoti SL, Ramesh J, et al. Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: A hospital-based study. Filaria J 2002;1:1.
45. Shenoy RK, Dalia S, John A, Suma TK, Kumaraswami V. Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations. Ann Trop Med Parasitol 1999;93:643-651
46. Shenoy RK, Suma TK, John A, Arun SR, Kumaraswami V, Fleckenstein LL, et al. The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole. Ann Trop Med Parasitol 2002;96:603-614
47. Sunish I P, Rajendran R, Mani TR, Dash A P, Tyagi BK. Evidence for the use of albendazole for the elimination of lymphatic filariasis. Lancet Infect Dis 2006;6:125-126
48. Sabesan S. Albendazole for mass drug administration to eliminate lymphatic filariasis. Lancet Infect Dis 2006;6:684-685
49. Ramaiah KD. Lymphatic filariasis elimination programme in India: Progress and challenges. Trends Parasitol 2009;25:7-8.
50. Babu B V, Kar SK. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Trop Med Int Health 2004;9:702-709
51. Lymphatic Filariasis: W.H.O. Wkly Epidemiol Rec 2007;82:361-380
52. Lahariya C, Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: An evaluation study. J Vector Borne Dis 2008;45:313-320
53. Global programme to eliminate lymphatic filariasis. W.H.O. Wkly Epidemiol Rec 2009;84:437-444
54. Sabesan S. Strategic options for global lymphatic filariasis elimination. Trends Parasitol 2003;19:200-201
55. Sabesan S. Need for site-specific change in strategy towards lymphatic filariasis elimination in India. Indian J Med Res 2008;127:10-11
56. Sabesan S, Raju KH, Srividya A, Das PK. Delimitation of lymphatic filariasis transmission risk areas: A geo-environmental approach. Filaria J 2006;5:1-12.
57. Sabesan S. Mapping of Lymphatic Filariasis: A way forward towards elimination. The Indian J Lymphol 2006;3:24-25
58. WHO, Report of a WHO informal consultation on epidemiological approaches to lymphatic filariasis elimination: Initial assessment, monitoring and certification. Atlanta, USA 1998. WHO/FIL/99.195. Geneva: WHO 1999. p. 35.
59. Ramaiah KD, Vijaya Kumar KN, Ravi R, Das PK. Situation analysis in a large urban area of India, prior to launching a programme of mass drug administration to eliminate lymphatic filariasis. Ann Trop Med Parasitol 2005;99;243-252
60. WHO Technical Report Series. Lymphatic filariasis: The disease and its control. Fifth report of the WHO Expert Committee on Filariasis; 1992. p. 42-43
61. Sabesan S. Human lymphatic filariasis is not a disease, but a syndrome. Curr Sci 2007;92:283-284
62. Rajagopalan PK, Kazmi SJ, Mani TR. Some aspects of transmission of Wuchereria bancrofti and ecology of the vector Culex pipiens fatigans in Pondicherry. Indian J Med Res 1977;66;200-215
63. Shriram AN, Krishnamoorthy K, Sehgal SC. Transmission dynamics of diurnally subperiodic lymphatic filariasis transmitted by Ochlerotatus (Finlaya) niveus in the Andaman and Nicobar Islands. Indian J Med Res 2008;127:37-43.
64. A great success in lymphatic filariasis control in China. National Technical Steering Group for Filariasis Control and Research, MOPH. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1995, 13, 81-85.